Registration is required, please click the following link to register online by May 3rd: https://catalyst.uw.edu/webq/survey/celiacc/368007 8:00 Continental Breakfast 8:25 – 8:30 Steven Kahn, MB, ChB, University of Washington
Introductory Remarks and Overview Session I – Chair: George Ioannou 8:30 – 9:10 Kitt Petersen, MD, Yale University
Mitochondria and the Liver 9:10 – 9:50 Sakeneh Zraika, PhD, University of Washington
Novel Mediators of Hepatic Glucose Production 9:50 – 10:30 Owen McGuinness, PhD, Vanderbilt University Regulation of Hepatic and Muscle Glucose Disposal during Infection and Inflammation 10:30 – 10:45 Coffee Break 10:45 – 11:25 Kristina Utzschneider, MD, University of Washington
NAFLD/NASH and Diabetes 11:25 – 12:05 Varman Samuel, MD, PhD, Yale University
NAFLD is a Disease for Endocrinologists: How Fatty Liver Leads to Hepatic Insulin Resistance 12:05 – 12:45 Sudha Biddinger, MD, PhD, Boston Children’s Hospital
Insulin Regulation of Lipid Metabolism and the Development of Hepatic Steatosis 12:45 – 2:00 Lunch Session II – Chair: Sakeneh Zraika 2:00 – 2:40 Jed Friedman, PhD, University of Oklahoma
Maternal Diet and the Microbiome Accelerates Pediatric NAFLD in Mouse, Monkey, and Man 2:40 – 3:30 George Ioannou, MD, University of Washington
Role of Cholesterol in Steatohepatitis 3:20 – 4:00 Kiran Bambha, MD, University of Washington
New Therapies for the Management of Fatty Liver Disease |